The 6-Month Antibody Durability of Heterologous Convidecia Plus CoronaVac and Homologous CoronaVac Immunizations in People Aged 18–59 Years and over 60 Years Based on Two Randomized Controlled Trials in China

Previous reports have shown that heterologous boosting with the AD5-vectored COVID-19 vaccine Convidecia based on a primary series of two doses of inactivated vaccine induces increasing immune responses. However, the immune persistence until 6 months after the heterologous prime-boost immunization w...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Hudachuan Jiang, Pengfei Jin, Xiling Guo, Jiahong Zhu, Xue Wang, Peng Wan, Jingxuan Wan, Jingxian Liu, Jingxin Li, Fengcai Zhu
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	MDPI AG 2023-12-01
Reeks:	Vaccines
Onderwerpen:	COVID-19 vaccine heterologous immunization prime-boost antibody durability
Online toegang:	https://www.mdpi.com/2076-393X/11/12/1815
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!